Skip to content

Fluocinonide

Corticosteroid — CARDIOVASCULAR SYSTEM

Also known as: flucetonide, fluocinolide, fluocinolide acetate, fluocinolone acetonide acetate

OfpFDA approvedATC C05AA11ATC D07AC08ATC D07CC05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Fluocinonide is an ofp drug in the Corticosteroid class catalogued in DrugCentral. It was first approved by the FDA in 1971. Its mechanism of action is classified as Corticosteroid Hormone Receptor Agonists. DrugCentral lists 2 molecular targets, including NR3C1 and PGR. Recorded indications include Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus and Eruption of skin.

  • Approval status: ofp (first approved 1971 by the FDA).
  • Drug class: Corticosteroid.
  • Mechanism of action: Corticosteroid Hormone Receptor Agonists.
  • Molecular targets: NR3C1 and PGR (2 listed in DrugCentral).
  • Indications: Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus, Eruption of skin and Granuloma annulare and others.
  • ATC code: C05AA11 (Corticosteroids).
  • Molecular formula: C26H32F2O7; molecular weight 494.53 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (13)

  • Atopic dermatitis
  • Contact dermatitis
  • Discoid lupus erythematosus
  • Eruption of skin
  • Granuloma annulare
  • Inflammatory dermatosis
  • Lichen simplex chronicus
  • Plaque psoriasis
  • Primary cutaneous T-cell lymphoma
  • Pruritus ani
  • Pruritus of genital organs
  • Scalp psoriasis
  • Seborrheic dermatitis

Contraindications (5)

  • Diabetes mellitus
  • Hypercortisolism
  • Hyperglycemia
  • Hypopituitarism
  • Infection of skin AND/OR subcutaneous tissue

Mechanism & targets

Mechanism of action (MoA)Corticosteroid Hormone Receptor Agonists
Established pharmacologic classCorticosteroid

Molecular targets (2)

TargetGeneActionActivity
Glucocorticoid receptorNR3C1agonistKi 8.62
Progesterone receptorPGRunknownKi 8.54

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1971-06-30FDA——

ATC classification

ATC codeTherapeutic hierarchy
C05AA11CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Corticosteroids
D07AC08DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, PLAIN › Corticosteroids, potent (group III)
D07CC05DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS › Corticosteroids, potent, combinations with antibiotics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Psoriasis394.9
Dermatitis atopic351.9
Drug ineffective277.1
Skin exfoliation227.8
Pruritus188.8
Rash143.8
Skin plaque134.4
Dry skin116.4
Product dose omission issue108.9
Eczema107.2
Papule105.0
Sleep disorder due to a general medical condition96.3

Chemical structure

Molecular formulaC26H32F2O7
Molecular weight494.53 g/mol
CAS number356-12-7
InChIKeyWJOHZNCJWYWUJD-IUGZLZTKSA-N
PubChem CID91488
CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Fluocinonide used for?

DrugCentral lists the following indications for Fluocinonide: Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus, Eruption of skin, Granuloma annulare, Inflammatory dermatosis, Lichen simplex chronicus and Plaque psoriasis and others.

How does Fluocinonide work?

Fluocinonide is classified as Corticosteroid Hormone Receptor Agonists; its molecular targets in DrugCentral include NR3C1 (agonist) and PGR.

When was Fluocinonide first approved?

Fluocinonide was first approved by the FDA in 1971.

What drug class does Fluocinonide belong to?

Fluocinonide is in the Corticosteroid class.

What is the chemical formula of Fluocinonide?

Fluocinonide has the molecular formula C26H32F2O7 and a molecular weight of 494.53 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1971-06-30
AgencyFDA
Targets2
Indications13
FormulaC26H32F2O7
DrugCentral ID1205
Interactive profile